Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 98051-98100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04793217
A Randomized Trial of ImpACT+, a Coping Intervention for HIV Infected Women With Sexual Trauma in South Africa
NAActive, not recruiting
350 participants
Started: Feb 18, 2021 · Completed: May 30, 2026
2 conditions3 sponsors1 location
NCT04761107
Impact of COVID-19 on GU Disease
N/AActive, not recruiting
15,240 participants
Started: Feb 18, 2021 · Completed: Feb 28, 2026
3 conditions1 sponsor1 location
NCT04649073
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Feb 18, 2021 · Completed: Jan 31, 2041
1 condition1 sponsor8 locations
NCT04759001
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
PHASE1/PHASE2Recruiting
52 participants
Started: Feb 18, 2021 · Completed: Aug 15, 2026
2 conditions1 sponsor1 location
NCT04757519
Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.
NAActive, not recruiting
403 participants
Started: Feb 18, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors21 locations
NCT04224779
Liquid Biopsies and IMAging for Improved Cancer Care
NAActive, not recruiting
16 participants
Started: Feb 18, 2021 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT04762953
Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
PHASE2Recruiting
40 participants
Started: Feb 18, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04410913
Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
PHASE2Active, not recruiting
20 participants
Started: Feb 18, 2021 · Completed: Feb 28, 2023
1 condition1 sponsor1 location
NCT04905160
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
NARecruiting
1,000 participants
Started: Feb 18, 2021 · Completed: Dec 22, 2026
3 conditions5 sponsors1 location
NCT04745559
Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
PHASE2Active, not recruiting
26 participants
Started: Feb 18, 2021 · Completed: Jun 30, 2027
5 conditions1 sponsor1 location
NCT04089046
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
NARecruiting
360 participants
Started: Feb 18, 2021 · Completed: Jun 30, 2027
1 condition3 sponsors1 location
NCT04750226
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
PHASE3Active, not recruiting
118 participants
Started: Feb 18, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor52 locations
NCT04679480
Anti-PD1-antibody and Pulsed HHI for Advanced BCC
PHASE2Active, not recruiting
20 participants
Started: Feb 18, 2021 · Completed: Dec 30, 2024
1 condition3 sponsors1 location
NCT04800874
Study of BBP-418 in Patients With LGMD2I
PHASE2Active, not recruiting
14 participants
Started: Feb 18, 2021 · Completed: Nov 1, 2026
1 condition1 sponsor1 location
NCT04792086
Disease Containment Measures Among Older Adults During the Covid-19 Pandemia
N/ARecruiting
12,000 participants
Started: Feb 18, 2021 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT04457622
Language and Brain Rhythms
NARecruiting
356 participants
Started: Feb 18, 2021 · Completed: Oct 18, 2026
1 condition1 sponsor1 location
NCT05923567
New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase
N/AActive, not recruiting
150 participants
Started: Feb 18, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04731857
Diagnostic Value of Exome/ Genome Sequencing, Conventional Methods in Rare Diseases and Familial Tumor Syndromes
N/ARecruiting
12,000 participants
Started: Feb 18, 2021 · Completed: Feb 28, 2027
2 conditions1 sponsor1 location
NCT04727931
Prevalence of Cognitive Disorders in Newly Diagnosed Epilepsy
N/ARecruiting
300 participants
Started: Feb 17, 2021 · Completed: Feb 1, 2026
2 conditions1 sponsor1 location
NCT04744116
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
EARLY_PHASE1Recruiting
24 participants
Started: Feb 17, 2021 · Completed: Mar 15, 2026
2 conditions2 sponsors1 location
NCT04591106
Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE
N/AEnrolling by invitation
190 participants
Started: Feb 17, 2021 · Completed: Jan 31, 2026
2 conditions3 sponsors1 location
NCT04682392
ACL Bone Health and Loading Study
NARecruiting
60 participants
Started: Feb 17, 2021 · Completed: Jan 1, 2025
1 condition2 sponsors1 location
NCT04545502
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
N/ARecruiting
2,000 participants
Started: Feb 17, 2021 · Completed: Jan 31, 2037
9 conditions1 sponsor31 locations
NCT04562532
Firehawk Rapamycin Target Eluting Coronary Stent North American Trial
NAActive, not recruiting
1,720 participants
Started: Feb 17, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor57 locations
NCT03943901
Split-Dose R-CHOP for Older Adults With DLBCL
PHASE2Active, not recruiting
26 participants
Started: Feb 17, 2021 · Completed: Feb 28, 2027
3 conditions2 sponsors1 location
NCT06424158
Massage Therapy After Thoracic or Lumbar Surgery
NARecruiting
100 participants
Started: Feb 17, 2021 · Completed: Aug 1, 2026
3 conditions1 sponsor1 location
NCT04623775
A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
PHASE2Active, not recruiting
468 participants
Started: Feb 17, 2021 · Completed: Feb 27, 2026
3 conditions1 sponsor125 locations
NCT04597307
IN.PACT™ Quality of Life Post-Reimbursement Study
N/AActive, not recruiting
80 participants
Started: Feb 17, 2021 · Completed: Dec 31, 2024
3 conditions1 sponsor9 locations
NCT06435585
Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
N/ARecruiting
5,000 participants
Started: Feb 17, 2021 · Completed: Dec 31, 2030
2 conditions2 sponsors1 location
NCT04557748
LURN: Urinary Urgency Phenotyping Protocol
N/AActive, not recruiting
840 participants
Started: Feb 17, 2021 · Completed: Dec 31, 2026
1 condition8 sponsors6 locations
NCT04167969
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
PHASE1Recruiting
16 participants
Started: Feb 17, 2021 · Completed: Nov 30, 2026
1 condition3 sponsors2 locations
NCT04214249
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia
PHASE2Active, not recruiting
48 participants
Started: Feb 17, 2021 · Completed: Jan 30, 2026
4 conditions1 sponsor10 locations
NCT04392037
Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone
PHASE2Active, not recruiting
60 participants
Started: Feb 17, 2021 · Completed: Dec 31, 2027
1 condition2 sponsors9 locations
NCT04502407
Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer
PHASE2Active, not recruiting
40 participants
Started: Feb 16, 2021 · Completed: Dec 15, 2029
1 condition1 sponsor4 locations
NCT04284787
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid Leukemia
PHASE2Active, not recruiting
60 participants
Started: Feb 16, 2021 · Completed: Jan 30, 2026
4 conditions1 sponsor29 locations
NCT04760301
Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
NARecruiting
60 participants
Started: Feb 16, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT04716309
Unstable Distal Radius Fractures With Dorsal Dislocation in Patients Aged 18-64 Years. Volar Locking Plate (VLP) vs Closed Reduction and Percutaenous Pinning (CRPP).
NAActive, not recruiting
120 participants
Started: Feb 16, 2021 · Completed: Dec 31, 2028
3 conditions2 sponsors1 location
NCT04767152
Evaluation of Brain Changes in ALL Patients on Therapy
NARecruiting
110 participants
Started: Feb 16, 2021 · Completed: Jan 21, 2026
1 condition1 sponsor1 location
NCT05784415
Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
N/AActive, not recruiting
30 participants
Started: Feb 16, 2021 · Completed: Aug 31, 2025
10 conditions2 sponsors1 location
NCT04576117
A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
PHASE3Active, not recruiting
300 participants
Started: Feb 16, 2021 · Completed: Dec 30, 2026
5 conditions1 sponsor101 locations
NCT04549571
Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions
NAActive, not recruiting
543 participants
Started: Feb 16, 2021 · Completed: Jan 31, 2027
22 conditions2 sponsors27 locations
NCT04405115
Improving Survivorship Care for Older Adults After Chemotherapy
NARecruiting
70 participants
Started: Feb 16, 2021 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT05748041
Multiparametric Approach to Identify a CMR-based Tricuspid Regurgitation Classification
N/ARecruiting
76 participants
Started: Feb 16, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04853420
Minimal Residual Disease: A Trial Using Liquid Biopsies in Solid Malignancies.
N/AActive, not recruiting
20 participants
Started: Feb 16, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04596384
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
NAActive, not recruiting
398 participants
Started: Feb 16, 2021 · Completed: Nov 30, 2026
4 conditions3 sponsors3 locations
NCT06043843
Effectiveness of Focused Tele-education in Reducing Diabetes Complications During Ramadan
NARecruiting
300 participants
Started: Feb 16, 2021 · Completed: Jun 30, 2026
3 conditions9 sponsors1 location
NCT04469959
Dopaminergic Dysfunction in Late-Life Depression
PHASE2Recruiting
100 participants
Started: Feb 15, 2021 · Completed: Jul 30, 2026
5 conditions5 sponsors2 locations
NCT04758793
Muscles in Liver Diseases
NANot yet recruiting
260 participants
Started: Feb 15, 2021 · Completed: May 31, 2026
1 condition1 sponsor0 locations
NCT04785508
Effects Neuromuscular Taping Technique on Upper Limbs Edema in Cardiac Surgery Patients
NARecruiting
10 participants
Started: Feb 15, 2021 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT04379570
Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy
PHASE3Active, not recruiting
1,167 participants
Started: Feb 15, 2021 · Completed: Aug 31, 2026
9 conditions2 sponsors526 locations